Table 4.
The influence of SLC22A1 and SLC47A1 polymorphisms on BMI and lipid profile.
| Polymorphism | BMI median (25–75%) |
P a | Total cholesterol median (25–75%) |
P a | HDL cholesterol median (25–75%) |
P a | LDL cholesterol median (25–75%) |
P a | TAG median (25–75%) |
P a | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
SLC47A1
rs2289669 |
GG | 30.0 (28.0–33.0) |
0.835 | 4.6 (3.9–5.5) |
0.018 | 1.2 (1.0–1.4) |
0.683 | 2.7 (2.0–3.5) |
0.070 | 1.7 (1.3–2.7) |
0.562 |
| GA | 29.0 (28.0–34.5) |
4.5 (3.6–5.0) |
1.1 (1.0–1.5) |
2.4 (1.9–3.2) |
1.6 (1.2–2.4) |
||||||
| AA | 29.0 (26.0–35.0) |
4.0 (3.4–4.2) |
1.1 (1.0–1.3) |
2.1 (1.9–2.5) |
1.5 (1.4–1.9) |
||||||
|
| |||||||||||
|
SLC22A1
rs628031 |
GG | 29.0 (28.0–34.0) |
0.387 | 4.5 (3.8–5.6) |
0.711 | 1.2 (1.0–1.4) |
0.096 | 2.5 (2.0–3.5) |
0.365 | 1.5 (1.2–2.2) |
0.569 |
| GA | 30.0 (27.1–32.0) |
4.4 (3.8–5.3) |
1.2 (1.0–1.5) |
2.4 (1.9–3.2) |
1.8 (1.3–2.5) |
||||||
| AA | 32.5 (28.3–34.0) |
4.2 (3.7–4.9) |
1.1 (0.9–1.3) |
2.4 (1.7–3.1) |
1.7 (1.2–2.9) |
||||||
aCalculated using Kruskal-Wallis test.